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Peripheral artery leiomyosarcoma
Sujit Vijay Sakpal, MD,a Rohin Mehta, MD,b Nitin Babel, MD,a and Ronald Scott Chamberlain, MD,
MPA,a,c Livingston and Newark, NJ
Vascular leiomyosarcomas are extremely rare tumors and represent only 0.001% of all malignancies. Venous leiomyosar-
comas occur five times more often than arterial ones, with 50% of them originating in the inferior vena cava (IVC).
Arterial leiomyosarcomas are most commonly encountered in the great vessels with less than 50% of them occurring in the
peripheral circulation. A total of only seven cases of arterial leiomyosarcomas involving the femoral artery have been
reported in literature to date. We report a case of an arterial leiomyosarcoma involving the profunda femoris artery, and
provide a comprehensive review on peripheral arterial leiomyosarcomas—distribution, clinical presentation, radiological
and histological diagnosis, staging, and treatment. (J Vasc Surg 2009;49:217-21.)CASE REPORT
A 65-year-old male presented with progressive left anterolat-
eral thigh pain, numbness, and tingling. Worsening pain unre-
lieved by analgesics, gradually and significantly began to reduce the
patient’s ability to ambulate and perform activities of daily living.
His extensive medical comorbidities included hypertension, diabe-
tes mellitus, hypercholesterolemia, and ischemic cardiomyopathy
with a myocardial infarction in the remote past. He admitted to a
history of cigarette smoking and alcohol consumption but quit
both 7 years ago. His family history was significant for lethal
coronary artery disease in his father.
On physical examination, vital signs were normal and perti-
nent findings were decreased flexional strength at the left knee
joint and loss of sensation over the left anterolateral thigh without
tenderness. He had bilateral ankle edema with palpable pedal
pulses. Lab tests were normal except for hemoglobin of 11.1 g/dl.
A lower extremity venous duplex scan revealed a deep venous
thrombosis (DVT) involving a small distal portion of his left
peroneal vein (treated with enoxaparin) and a mass in his left thigh.
Amagnetic resonance imaging (MRI) study of his left thigh (Fig 1)
was performed which revealed a well-circumscribed, lobulated,
enhancing mass measuring 6.5  3.2 cm2. The mass appeared to
involve the femoral nerve and was positioned immediately poste-
rior to the femoral artery and vein with no evidence of muscle or
bone infiltration. These findings suggested a benign nerve sheath
tumor arising from the femoral nerve.
Neurosurgery consultation was obtained, and the decision was
made by the neurosurgeon to take the patient for operative explo-
ration rather than initial core biopsy. A left anterior thigh incision
revealed an oval-shaped tumor in the vertical axis. The mass was
identified and felt to be of non-neural etiology, and application of
a neural stimulator evoked no response. A small incisional biopsy
was obtained, which revealed a high-grade soft tissue sarcoma on
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tempted until a work-up was completed.
At this point, the patient was referred to a surgical oncologist
and metastatic work-up was negative. He underwent re-explora-
tion with planned en bloc resection. A plane was created between
the vastus medialis and the quadriceps femoris muscles, and the
superficial femoral artery, vein, and nerve were retracted medially
revealing an expansile mass in association with the profunda fem-
oris artery. Large thigh collaterals arising from the profunda prox-
imal to the tumor were identified. An en bloc excision of the tumor
together with the profunda femoris artery was performed, with
proximal and distal arterial ligation. The length of the resected
profunda femoris artery was 5.6 cm and contained a fusiform
tumormass (2.3 cm transversely) (Fig 2,A) distal to the large thigh
collaterals. Longitudinal cross-section of the specimen revealed a
fleshy, grey-tan, nodular, well-circumscribed, myxoid mass (mea-
suring 2.3 cm in greatest dimension) growing within the arterial
wall and protruding into the lumen (Fig 2, B). Transverse cross-
section of the specimen showed the gelatinous, myxoid tumor
within the arterial media, external to the intima and internal to the
serosa.
Histopathological examination of the mass revealed a high
nuclear grade with closely packed interlacing bundles of multinu-
cleated, giant spindle cells; elongated cigar-shaped hyperchromatic
nuclei embedded within an abundant granular, eosinophilic cyto-
plasm; atypical mitoses (5 mitoses/10 hpf); and areas of necrosis
and fibrosis within the tissue (Fig 3, A). These findings were
diagnostic for a high-grade soft tissue sarcoma consistent with an
arterial leiomyosarcoma. Longitudinally, the proximal and distal
margin of the profunda femoris artery was free of tumor involve-
ment, however, the tumor extended through the serosa into the
surrounding adipose tissue. The tumor was stage IIB according to
the American Joint Commission on Cancer staging system for
soft-tissue sarcomas (see Table I), and stage IIb according to the
surgical staging system of the Musculoskeletal Tumor Society for
bone and soft tissue sarcomas (see Table II). Immunohistochem-
ical staining of the tumor cells revealed strong positivity for smooth
muscle specific markers actin (Fig 3, B) and vimentin confirming a
leiomyosarcoma, and negativity for S-100 (tumor marker for mel-
anomas, malignant peripheral nerve sheath tumors and clear cell
sarcomas), CD 34 (tumor marker for dermatofibrosarcomas, gas-
trointestinal stromal tumors, and malignant peripheral nerve
sheath tumors), and CD 68 (hematopoietic differentiation marker
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excluding a metastatic lesion.
Postoperatively, the patient had an uneventful recovery and
was discharged home on hospital day 3. Treatment for DVT
continued with enoxaparin and adjuvant radiation therapy was
initiated.
DISCUSSION
Leiomyosarcomas are aggressive soft tissue sarcomas
arising from smooth muscle cells typically of uterine, gas-
trointestinal, or soft tissue origin. Embryologically soft
tissues originate from the mesoderm, and soft tissue sarco-
mas are malignant tumors that arise from mesenchymal
cells. Primary tumors originating in the blood vessels are
extremely rare, and vascular leiomyosarcomas are even
rarer. Vascular leiomyosarcomas arise from smooth muscle
cells lining blood vessels and may present with signs and
symptoms of vascular compromise and/or neurologic
symptoms from compression of adjacent nerves. While soft
tissue sarcomas account for 0.7% of all malignancies,
leiomyosarcomas represent only 5% to 7 % of soft tissue
sarcomas, and only 2% of these are of vascular origin.1
Vascular leiomyosarcomas occur most commonly in the
adult population (age range 37-80 years) and with no
Fig 1. Magnetic resonance imaging (MRI) of the left th
toD) in the anteromedial thigh compartment and in clos
(left lateral sagittal view) and (D) (axial view) depict the
to the femur and immediately posterior to the femoral n
weighted) present the mass in a coronal plane.gender preference.2Vascular leiomyosarcomas involving veins are five times
more common than those involving arteries. In a review of
86 cases, vascular leiomyosarcomas involved veins 79% of
the times (68 cases) with a majority (33/68 cases) involv-
ing the inferior vena cava (IVC).3 Arterial leiomyosarcomas
were seen 21% (18/86 cases) of the time with a majority of
them occurring in the pulmonary artery (56%, 10/18
cases). In addition to arterial leiomyosarcomas of the pul-
monary artery, other reported sites include the aorta,4-6
renal,7 popliteal,1 splenic,8 subclavian,9 carotid,10 iliac,11
and common femoral12 and superficial femoral2,13 arteries.
Arterial leiomyosarcomas originating in the femoral artery
are extremely rare, and only seven cases have been reported
in the literature to date (Table III).
Symptoms related to arterial leiomyosarcomas vary
widely according to the location of the tumor. Peripheral
arterial leiomyosarcomas have a predilection for the lower
limb arteries with a majority of them occurring in the
popliteal arteries,1 and they most commonly present with
symptoms of claudication. Arterial leiomyosarcomas are
slow growing and usually present due to symptoms related
to luminal narrowing7,12,14 or peripheral embolization.5
This accounts for the fact that they are frequently misdiag-
nosed as atherosclerotic chronic occlusive disease12,13 or
evealed a well-circumscribed, oval mass (white arrow, A
ximity to the femoral neurovascular bundle. Images (A)
eighted contrast-enhanced images of the tumor medial
ascular bundle. Images (B) (T-2 weighted) and (C) (T-1igh r
e pro
T-1 w
euroveven as aneurysms if they present as pulsatile masses.2 These
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tumor within the vessel wall (star,A andB), and extension of the tumor into the distal arterial trifurcation (solid arrows,
A and B). Longitudinal cross-section of the specimen (B) revealed an intact intima lined arterial lumen (metal pointer)
encased by the tumor (stars).Fig 3. A, Histology of the tumor (hematoxylin-eosin stain, 40) revealed spindle-shaped, pleomorphic neoplastic
cells with hyperchromatic, atypical, elongated nuclei and fibrillary eosinophilic cytoplasm. B, The neoplastic cells
exhibited strong and diffuse cytoplasmic immunoreactivity for actin (hematoxylin-eosin stain,20). Both, (A) and (B)
depicted characteristic features of a leiomyosarcoma.
JOURNAL OF VASCULAR SURGERY
January 2009220 Sakpal et altumors may also compress adjacent nerves causing neuro-
logic symptoms1,7,13as was reported in our patient. Overall,
arterial leiomyosarcomas tend to behave more aggressively
than their venous counterparts,1,6 and those arising within
the intima are typically poorly differentiated with a higher
metastatic potential due to direct arterial seeding. Whereas
arterial leiomyosarcomas arising within the media tend to
be better differentiated, and direct arterial seeding is not
their feature until the tumor invades through the intima.6
Vascular imaging such as duplex ultrasonography,13
computed tomography (CT) angiography,1,4,13,15 and
conventional arteriography2,12 can reveal an intravascular
filling defect, but they cannot differentiate between a sar-
coma and a thromboembolic process causing it, with inva-
sive arteriography carrying the risk of precipitating tumor
embolization.16 If suspected, the diagnostic evaluation for
a vascular leiomyosarcoma should begin with a MRI of the
lesion and a CT scan of the chest, abdomen, and pelvis.
MRI evaluates the anatomic extent of the tumor and in-
volvement of the adjacent bone, nerves, or vascular struc-
tures. In addition, it provides a multiplanar image of the
lesion that can differentiate a tumor from atheromatous
material through enhancement of the tumor on T-1
weighted and T-2 weighted images without the risk of
embolization.16 CT scan of the chest, abdomen, and pelvis
can detect metastases in the lungs and liver, the two most
common sites of metastases of vascular leiomyosarcomas. A
biopsy is essential to establish a definitive diagnosis, and
while both a core needle biopsy under radiological guid-
ance and an open procedure can be performed, the former
Table I. The American Joint Committee on Cancer
(AJCC) staging system for soft- tissue sarcomas
Stage
Histologic
grade Size
Location
(Relative to fascia) Metastases
IA Low 5 cm Superficial or deep No
IB Low 5 cm Superficial No
IIA Low 5 cm Deep No
IIB High <5 cm Superficial or deep No
IIC High 5 cm Superficial No
III High 5 cm Deep No
IV Any Any Any Yes
The tumor features of the current case are bolded in the table.
Table II. The surgical staging system of the
Musculoskeletal Tumor Society (MSTS) is used for bone
and soft tissue sarcomas, including leiomyosarcomas
Stage
Histologic
grade
Local extent
of disease Metastases
Ia Low Confined No
Ib Low Unconfined No
IIa High Confined No
IIb High Unconfined No
III Any Any Yes
The tumor features of the current case are bolded in the table.technique is favored due to less morbidity.Pathologically, a leiomyosarcoma can be identified un-
der light microscopy on hematoxylin-eosin (H&E) stain-
ing. Specific features include a highly cellular field with
abundant pink to red cytoplasm and centrally located classic
cigar-shaped nuclei, as well as the presence of myofibrils
that run longitudinally along the cell’s length. A malignant
leiomyosarcoma can be differentiated from a benign
smooth muscle tumor based on features such as size, cellu-
larity, atypia, necrosis, and mitoses per high power field.
Specifically, increased cellular mitoses along side atypia
and/or focal necrosis should raise the suspicion of a malig-
nant process. Additionally, immunohistochemical staining
supports the diagnosis of a leiomyosarcoma by demonstrat-
ing muscle specific markers such as desmin, actin, and
vimentin. Metastatic vascular lesions can be excluded by
the absence of immunohistochemical staining for S-100
protein and HMB-45 (melanoma); chromogranin, synap-
tophysin, and neuron specific enolase (neuroendocrine tu-
mors); carcinoembryonic and epithelial membrane anti-
gens (epithelial tumors); and CD 20, CD 30, CD 43, and
CD 99 (hematolymphoid tumors).16 Electron microscopy
can further illustrate the classic nuclear morphology of
leiomyosarcomas.
The tumor’s local anatomic extent and its metastatic
status derived from imaging modalities (MRI and CT) in
combination with its histological grade can be utilized to
stage the disease (see Tables I and II) and suggest appro-
priate therapy.
Treatment of vascular leiomyosarcomas typically in-
volves surgical resection of the involved vascular segment
with negative margins. In the absence of collaterals, vascu-
lar reconstruction with interposition grafts is often re-
quired. Many of these tumors may involve or are adjacent
to vital structures making wide surgical margins not feasi-
ble. In such cases, radiation is a vital neoadjuvant therapeu-
tic tool, especially in high-grade sarcomas, to provide local
control. Radiation therapy can also be utilized as an adju-
vant after resection of the primary tumor, or for palliation in
patients with extensive metastases. Chemotherapy may be
beneficial as an adjuvant in localized disease1 and should be
considered for large high-grade or recurrent sarcomas.
In summary, leiomyosarcomas of vascular origin are
rare malignant tumors. Prognosis is related to stage at
presentation and surgical resectability. Delay in diagnosis
often makes en bloc surgical resection difficult if not impos-
sible. Metastatic disease to the lungs, liver, and lymph
nodes occurs in 60% of patients with these tumors.3 The
5-year survival rate with vascular leiomyosarcomas is 36%,
with an average survival of 16 months.1,3 Though early
diagnosis of vascular leiomyosarcomas is uncommon, these
tumors should be on the differential diagnoses in any
vasculopathy with atypical features, or when neurologic
symptoms thought to be caused by a mass in close proxim-
ity to vascular structures is identified, or when an isolated
intraluminal filling defect is identified on arteriography.12
Both MRI and CT are vital in evaluating local and systemic
extent of the disease, respectively. Management of vascular
leiomyosarcomas should involve early imaging and his-
JOURNAL OF VASCULAR SURGERY
Volume 49, Number 1 Sakpal et al 221topathological tissue examination, with subsequent staging
of the disease. Surgical treatment aimed at achieving a R0
resection followed, when appropriate, by adjuvant radia-
tion and/or chemotherapy should then be initiated.
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